Search Results

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

At the end of his studies, he was awarded the Pfizer Prize for undergraduate research. At the MRC he developed novel prostate cancer therapeutics based upon his research into GPCR pluridimensional At the NIH he was the recipient of the coveted NIH ‘Bench-to-Bedside’ Translational Research Grant Award Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based This research stream is now forming the basis of a new technology-based start-up company, HeptOME , to

Our work helps biotech startups, research organizations, and CROs design operating systems that enable GPCR, we help organizations: ✅ Clarify vision and direction ✅ Translate research milestones into measurable

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Collaborative Research and Translational Approach Arthur and Yamina from Monash University discussed GPCR researchers in Australia and the initiation of a successful series of conferences. approach to research and its capacity to translate research into therapeutic commercialization. Translating Discovery Into Clinical Application Arthur and Yamina discussed the importance of translating

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and Collaborative Research and Translational Approach Arthur and Yamina from Monash University discussed GPCR researchers in Australia and the initiation of a successful series of conferences. approach to research and its capacity to translate research into therapeutic commercialization. Translating Discovery Into Clinical Application Arthur and Yamina discussed the importance of translating

<< Back to podcast list Strategic Partner(s) Translating computational approaches to GPCR biologists Now in a tenure-track position, his research spans the development of computational methods such as structure-based Ricardo Capelli on the web Google Scholar ResearchGate Bysky App : @ riccardocapelli.bsky.social Twitter the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Raimond Heukers , developed a nanobody platform within the research group and used this platform to develop During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research

Date & Time Friday, November 3rd / 8:30 AM Abstract Coming Soon About Mario Tiberi "I did my graduate research My addiction for dopamine led me to the Ottawa Hospital Research Institute (then the Moses and Rose Loeb Research Institute) to develop my independent research program. We are also currently developing the translational component of our research to capitalize on the druggability We hope our research will aid in the development of new therapeutic interventions for the alleviation

Funded through three consecutive Wellcome Trust Senior Research Fellowships Andrew established a reputation Now at the University of Glasgow, his primary research interests are focused on the rational design of In this Andrew runs a research laboratory of around 15 staff supported by basic research grants investigating The vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma research.

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and His main research group centers on the function, structure, and regulation of G protein-coupled receptors His experience also includes translating knowledge generated into the selection of targets, screening Milligan has published more than 550 peer-reviewed articles and his research has been cited more than the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

Gainetdinov is the Institute of Translational Biomedicine Director at Saint Petersburg State University Gainetdinov was a Senior Researcher in the Department of Neuroscience and Brain Technologies at the Italian Institute of Technology in Genova, Italy (2008-2016) and an Associate Research Professor in the Department joining the Department of Cell Biology in 1996 as a postdoc and becoming faculty at Duke in 2000, he researched Gainetdinov was included in the Web of Science (WOS) Highly Cited Researchers (HCR) list, representing

GPCR unites researchers, industry, and partners to accelerate GPCR science and drug discovery—through Our Vision A world where GPCR insights translate quickly into real‑world therapies through an open, trusted What We Do (in Three Verbs) Connect — Researchers, founders, students, and industry partners meet, learn Join To join the community, you should be actively related to the GPCR field , including: Academic researchers Partner perks: Direct interaction with researchers, founders, and decision‑makers Access to all member

Industry Collaboration How do GPCR tools move from individual academic labs into broad use across the research Joining the conversation are Maria Majellaro (CSO and co-founder of Celtarys Research), Johannes Broichhagen Listeners will walk away with a clearer view of how academic innovation translates into tools for high-throughput at the CIQUS Research Center in Spain. By integrating advanced tools and translational biology, his work directly informs therapeutic strategies

Alex Serafini shares why pain research must start with real-world behavior and models before drilling by personal experience and a desire to innovate in pain management, Alex pursued a master's in pain research “I started going through what I was going through… and that got me very interested in research.” — Alex Pivoting: Redefining the Pain Research Playbook Looking ahead, Serafini’s vision is bold: build a lab Keyword Cloud GPCR research community, Dr.

Lauren Slosky About Irfan Dhanidina "My interest in oncology research led me to pursue a BSc in Biology GPCR research into novel therapies for patients. " Irfan Dhanidina on the web LinkedIn The Org DIBIZ Slosky’s research is focused on understanding how neuropeptide G protein-coupled receptors (GPCRs) regulate Slosky’s work has been recognized through several travel and research awards, including the William James In addition to research, Dr.

Why This Matters Translating basic GPCR science into actual medicines is broken. Learn in This Episode How Ajay’s failed MD/PhD application rerouted his path toward a breakthrough GPCR research Who Should Listen PhD students and postdocs exploring biotech careers GPCR scientists interested in translational Ajay’s work sits at the intersection of GPCR biology, AI, and translational medicine. the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

His postdoctoral training included research at the École Polytechnique Fédérale de Lausanne (2015–2016 ) and later at the Max Planck Institute for Medical Research in Heidelberg, where he served as both postdoc Since 2020, JB has led his research group at the Leibniz Research Institute for Molecular Pharmacology Johannes Broichhagen on the Web LinkedIn Google Scholar Lab Website Leibniz Research Institute for Molecular the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

Discover how Celtarys Research is transforming GPCR assay development with fluorescent ligands in this GPCR and Celtarys, built on a shared commitment to empowering the GPCR research community. Translating Science into Business Like many scientists-turned-entrepreneurs, Maria faced the challenge Keyword Cloud GPCR research community , Dr. Jhonny Azuaje they laid the groundwork for the future creation of Celtarys Research.

Sharpen your edge with allosteric bias, residence time, and translational PK/PD. Sharpen your edge with allosteric bias, residence time, and translational PK/PD.

This competition invites creative minds to make a captivating logo representing the essence of GPCR research GPCRs play critical roles in many physiological processes, making them a focal point of scientific research are encouraged to incorporate material that reflects the diverse fields of study encompassing GPCR research , such as biochemistry, pharmacology, structural biology, and translational medicine.

questions of how Adhesion GPCRs integrate the different signals on a molecular level and how these are translated Simone Prömel on the web Prömel Lab Pubmed Researchgate Twitter Dr. GPCR Ecosystem About Dr. Ines Liebscher on the web Website LinkedIn Researchgate Dr. GPCR Ecosystem Enjoying the Dr. the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

About John Stagg "John Stagg is a Professor of Pharmacy at Université de Montréal and researcher at the CHUM Research Centre. recognized for having identified the adenosine-producing enzyme CD73 as a new cancer target, and for his translational Stagg on the web University of Montréal Québec Cancer Consortium The University of Montreal Hospital Research

Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK Sharpen your edge with allosteric modulation, residence time, molecular dynamics, and translational PK

Adriano’s research has contributed to our understanding of the role that ubiquitin plays in GPCR signaling the mechanisms that govern spatial and temporal regulation of GPCR signaling by -arrestins and post-translational The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

Biology, Duke Trinity College of Arts and Sciences, Durham, NC 27710. 3-National Center for Advancing Translational I am currently completing my postdoctoral research in the laboratory of the late Dr. Marc Caron (2019-2023) and subsequently, will begin my independent research career as a tenure-track My broad research interest is to better understand the underlying mechanisms of food reward and its downstream

Prior to joining Heptares, Chris was a neuroscience researcher at GlaxoSmithKline, UK (1998-2009). editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience, ACS Pharmacology & Translational He has published over 70 research articles, reviews and book chapters on drug discovery, which have been the team Recent Podcast Articles Asking Better Questions in Science: A Practical Guide for Emerging Researchers

GPCRs are among the most powerful and complex targets in biomedical research. He currently leads Revvity's Research and Development activities, focusing on biochemical and cellular In 2020, together with her team, she initiated a long-term research effort that enabled the creation GPCR, the global nonprofit platform dedicated to advancing GPCR research and drug discovery, is proud Eric Trinquet, Director of Research and Development at Revvity.